Testosterone-induced growth of S115 mouse mammary tumor cells is dependent on heparan sulfate

Experimental Cell Research

Volumn 264, Issue 2, 2001, Pages 307-314

  Borgenström, Marjut ^a   Tienhaara, Anri ^a   Spillmann, Dorothe ^b   Salmivirta, Markku ^a,b,c   Jalkanen, Markku ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b UPPSALA UNIVERSITY   (Sweden)

^c Biotie Therapies Corp   (Finland)

Author keywords

Breast cancer; Heparin; Proteoglycan; Syndecan; Transformation

Indexed keywords

CARBOHYDRATE; FIBROBLAST GROWTH FACTOR RECEPTOR; HEPARAN SULFATE; HEPARIN; OLIGOSACCHARIDE; PROTEOGLYCAN; SODIUM CHLORATE; SYNDECAN; TESTOSTERONE;

ANIMAL CELL; ARTICLE; BREAST CARCINOGENESIS; BREAST TUMOR; CELL PROLIFERATION; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SULFATION; TUMOR GROWTH;

EID: 0035298056     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.5126     Document Type: Article

References (40)

1. Correlation of growth properties and morphology with hormone responsiveness of mammary tumor cells in culture
2. Inhibitory effect of antibody against basic figroblast growth factor on androgen- or glucocorticoid-induced growth of Shionogi carcinoma 115 cells in serum-free culture
3. Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells
4. Signal transduction by receptors with tyrosine kinase activity
5. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation
6. Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4
7. Heparin structure and interactions with basic fibroblast growth factor
8. Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation
9. Heparan sulfate: A piece of information
10. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor
11. Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity
12. Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2
13. Characterization of fibroblast growth factor 1 binding heparan sulfate domain
14. Steroid-induced epithelial-fibroblastic conversion associated with syndecan suppression in S115 mouse mammary tumor cells
15. Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck
16. Cells selected for high tumorigenicity or transformed by simian virus 40 synthesize heparan sulfate with reduced degrees of sulfation
17. Basement-membrane heparan sulphate with high affinity for antithrombin synthesized by normal and transformed mouse mammary epithelial cells
18. Structural differences between heparan sulphates of proteoglycan involved in the formation of basement membranes in vivo by Lewis-lung-carcinoma-derived cloned cells with different metastatic potentials
19. Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro
20. Selective reduction of 6-O-sulfation in heparan sulfate from transformed mammary epithelial cells
21. Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells
22. Structural requirement of heparan sulfate for interaction with herpes simplex virus type 1 virions and isolated glycoprotein C
23. Defining the interleukin-8-binding domain of heparan sulfate
24. Suppression of tumor cell growth by syndecan-1 ectodomain
25. Growth control of androgen-dependent Shionogi carcinoma cells by growth factor(s) produced from androgen-independent Shionogi carcinoma cells in a paracrine mechanism
26. Growth stimulation by androgens, glucocorticoids or fibroblast growth factors and the blocking of the stimulated growth by antibody against basic fibroblast growth factor in protein-free culture of Shionogi carcinoma 115 cells
27. Cleavage of structural proteins during assembly of the head of bacteriophage T4
28. Heparin inhibits autocrine stimulation but not fibroblast growth factor stimulation of cell proliferation of androgen-responsive Shionogi carcinoma 115
29. Modulation of cell surface heparan sulfate structure by growth of cells in the presence of chlorate
30. Androgen and fibroblast growth factor (FGF) regulation of FGF receptors in S115 mouse mammary tumor cells
31. Androgen-induced growth factor and its receptor: Demonstration of the androgen-induced autocrine loop in mouse mammary carcinoma cells
32. Growth-stimulatory effects of androgen, high concentration of glucocorticoid or fibroblast growth factors on a cloned cell line from Shionogi carcinoma 115 cells in a serum-free medium
33. A role for heparan sulfate in androgen-induced deoxyribonucleic acid synthesis of mouse mammary carcinoma (Shionogi carcinoma 115)-derived SC-3 cells
34. FGF-8 isoforms activate receptor splice forms that are expressed in mesenchymal regions of mouse development
35. Receptor specificity of the fibroblast growth factor family
36. Inhibition of basic fibroblast growth factor-induced growth promotion by overexpression of syndecan-1
37. Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells
38. Differential regulation of FGF-1 and -2 mitogenic activity is related to their kinetics of binding to heparan sulfate in MDA-MB-231 human breast cancer cells
39. The proliferative and migratory activities of breast cancer cells can be differentially regulated by heparan sulfates